ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,282.00
      1.43%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.515
      -0.93%
      Bitcoin
      67,642.02
      -0.76%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Seres Therapeutics Inc (MCRB)

      7. Seres Therapeutics Inc (MCRB) Financials

      Seres Therapeutics Inc

      Seres Therapeutics Inc (MCRB)

      NASDAQ
      1.221
      -0.004
      (-0.33%)
      At close: July 22 4:00PM
      Delayed by 15 minutes
      1.21
      -0.011
      ( -0.90% )
      After Hours: 6:09PM
      Delayed by 15 minutes

      Seres Therapeutics Inc Financial Summary

      The current MCRB market cap is 183.25M. The company's latest EPS is USD -0.7509 and P/E is -1.62.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue -522k126.47M310k64k0
      Operating Income -70.57M45.92M-47.41M-44.72M-39.59M
      Net Income -71.17M46.55M-47.85M-41.25M-40.13M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 34.51M33.22M146.66M7.13M126.33M
      Operating Income -71.88M-88.13M-64.49M-246.49M-107.98M
      Net Income -70.28M-89.13M-65.58M-250.16M-113.72M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 270.19M406.39M367.7M358.6M341.26M
      Total Liabilities 318.07M383.77M382.82M403.46M401M
      Total Equity -47.87M22.61M-15.12M-44.86M-59.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 132.44M342.94M354.86M348.78M358.6M
      Total Liabilities 180.76M168.19M223.35M338M403.46M
      Total Equity -48.32M174.75M131.51M10.78M-44.86M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -76.58M-10.6M-69.86M-117.35M-35.24M
      Investing 2.74M13.26M11.46M10.58M-62k
      Financing 5.66M63.83M65.28M71.71M18.41M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -76.52M-93.61M6.69M-228.82M-117.35M
      Investing -30.52M-158.89M64.09M82.43M10.58M
      Financing 86.23M303.42M1.18M129.6M71.71M

      Stats and Ratios

      Market Cap 183.25M
      Price to Earnings Ratio -1.62
      Price to Sales Ratio 1.46
      Price to Cash Ratio 1.44
      Price to Book Ratio -4.12
      Dividend Yield -

      Share Statistics

      Shares Outstanding 151.45M
      Average Volume (1 week) 7.05M
      Average Volume (1 Month) 4.21M
      52 Week Change -73.70%
      52 Week High 5.29
      52 Week Low 0.54
      Spread (Intraday) 0.01 (0.81%)

      Company Info

      Company Name Seres Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.serestherapeutics.com
      Industry pharmaceutical preparations (2834)